REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biomantis Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Biomantis Sp. z o.o. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Biomantis Sp. z o.o is a company that specializes in biochirurgy, specifically focusing on the treatment of unhealing wounds through debridement therapy. Their scientific and research facilities are located in the Park Life Science Jagiellonian Center for Innovation.

Headquarters
Ul. Podlesie 5/36
Krakow; Malopolskie; Postal Code: 30-667

Contact Details: Purchase the Biomantis Sp. z o.o. report to view the information.

Website: http://www.biomantis.pl

Basic Information
Total Employees:
Purchase the Biomantis Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Biomantis Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Biomantis Sp. z o.o. report to view the information.
Incorporation Date:
September 09, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biomantis Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
0.31%▲
Total operating revenue
-0.54%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-6.78%▼
Total equity
-13.76%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.51%▼
Cash Ratio
-0.39%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo